Polyomavirus-associated nephropathy: update on antiviral strategies.
about
Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantationLeflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation.BK Virus-associated Hemorrhagic Cystitis in Patients with Allogeneic Hematopoietic Cell Transplantation: Report of Three CasesPolyomavirus BK infection in blood and marrow transplant recipients.Repression of BK virus infection of human renal proximal tubular epithelial cells by pravastatin.Polyomavirus BK neutralizing activity in human immunoglobulin preparations.Trichodysplasia of immunosuppression treated with oral valganciclovir.Synthesis and structure–activity relationships of small molecule inhibitors of the simian virus 40 T antigen oncoprotein, an anti-polyomaviral targetImpact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremiaA screen for modulators of large T antigen's ATPase activity uncovers novel inhibitors of Simian Virus 40 and BK virus replication.Leflunomide inhibits the apoptosis of human embryonic lung fibroblasts infected by human cytomegalovirus.Antivirals for the treatment of polyomavirus BK replication.Transforming growth factor-beta-mediated regulation of BK virus gene expression.Viral infection after renal transplantation: surveillance and management.Use of leflunomide in the treatment of polyomavirus BK-associated nephropathy.The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment.Anion homeostasis is important for non-lytic release of BK polyomavirus from infected cells.Evaluation of leflunomide for the treatment of BK viremia and biopsy proven BK nephropathy; a single center experience.Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains.Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients.Allograft adenovirus nephritis.Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy.BK polyomavirus in solid organ transplantation.Anti-DNA Virus AgentsEmerging antiviral drugs
P2860
Q24627138-AE2EFE97-121B-4F33-BFDD-74FB4EFEC531Q33376066-65F4EB84-31CA-483F-9E92-396DA50101E6Q33863365-4B26742B-D856-47D8-BBCE-C51C0FFE6736Q34732733-E351A564-8395-4C33-B502-128590B1DA0CQ34778299-83380816-D7CC-465A-9301-B9ADC705017AQ34786755-2CC922EB-5FB8-4DE5-90C8-7A962B37C804Q34909585-4A785F4A-B149-404F-8BAA-239FDF9B3540Q34944346-F599B649-BB3F-4A7A-8B67-2E525E1D1435Q35930371-45EA80E5-1584-49B3-8864-92BEF40751C6Q36301133-43B4271E-E894-4378-87A9-D8506436FE18Q36686842-C9B1B582-159E-4F88-9798-A28DB63E977DQ36723806-8645D6E5-AD2F-4F05-BD9C-5A74891FD344Q36942336-D87BA70A-6FD7-4005-8597-AD61097F8A0EQ37097708-2317AA30-A8CF-4940-A6C4-AB95C30B41FEQ37310698-A8BCEBF1-27F4-452E-8F08-67D3C656DDF1Q37821326-45944CF4-1416-4A76-BF2C-CA755D9E342DQ38846030-F73E4019-989A-4DFA-BC3E-014A3F692260Q38974625-EE061054-999F-49EC-A1E6-BDC29AC512F5Q40147617-5D224804-FF17-44B2-83C9-63FB06089EABQ41548443-355C3173-82D7-41EF-958D-D5FEC645F256Q42150045-A12DDB2D-5FEA-4E82-BE35-BEC8121F2F2EQ42268339-552B8FFC-7B80-4D1A-9F6E-316BA7BF039BQ42272314-A27D7027-F9E1-4655-BB94-04EF7AC16E6AQ56786267-5B349273-11D0-4AAD-A545-58BD644403CEQ56786308-E504939C-6FE7-43BF-91BD-5ECC0A4622DD
P2860
Polyomavirus-associated nephropathy: update on antiviral strategies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Polyomavirus-associated nephropathy: update on antiviral strategies.
@ast
Polyomavirus-associated nephropathy: update on antiviral strategies.
@en
type
label
Polyomavirus-associated nephropathy: update on antiviral strategies.
@ast
Polyomavirus-associated nephropathy: update on antiviral strategies.
@en
prefLabel
Polyomavirus-associated nephropathy: update on antiviral strategies.
@ast
Polyomavirus-associated nephropathy: update on antiviral strategies.
@en
P2093
P2860
P1476
Polyomavirus-associated nephropathy: update on antiviral strategies.
@en
P2093
A Chandraker
J W Williams
M A Josephson
P S Randhawa
P2860
P304
P356
10.1111/J.1399-3062.2006.00150.X
P577
2006-06-01T00:00:00Z